01 8Zyvox
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 251
2018 Revenue in Millions : 236
Growth (%) : 6
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 222
2019 Revenue in Millions : 251
Growth (%) : -12
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 173
2020 Revenue in Millions : 222
Growth (%) : -22
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2014 Revenue in Millions : -0.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2015 Revenue in Millions : 1,352
2014 Revenue in Millions : 883
Growth (%) : -35%
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 421
2015 Revenue in Millions : 883
Growth (%) : -52
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 281
2016 Revenue in Millions : 421
Growth (%) : -33
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 236
2017 Revenue in Millions : 281
Growth (%) : -16%
LOOKING FOR A SUPPLIER?